PSM announces highly promising zinc-silver results and $1.9M cap raise
ASX explorer Peninsula Mines (ASX:PSM) has today delivered a double dose of good news. The company has intersected two massive and disseminated sulphides at its Ubeong Zinc-Silver Project in South Korea.
On top of that, PSM has settled its recently completed, heavily oversubscribed placement, receiving funds to the tune of A$1.9 million. This places the company in an excellent cash position to continue its focused drilling program at Ubeong.
Massive disseminated sulphides intersected at Ubeong Project
PSM has intersected two massive and blebby/disseminated zinc-silver and silver-lead-copper bearing sulphide zones in diamond drill-hole UBD0003 at its Tiger Target in the Chilbo historical workings area of the Ubeong Project. Results include:
- A 10.65 metre intersection of blebby and semi-massive arsenopyrite, pyrrhotite, galena and chalcopyrite with high grade XRF results of up to 4,568 grams per tonne of silver, 2.97 percent lead and 0.7 percent copper and;
- A 2.22 metre intersection of massive and blebby/disseminated arsenopyrite and sphalerite with high-grade XRF results of up to 15.24 percent zinc and 949 grams per tonne silver.
The two sulphide intersections occur down dip of outcropping massive sulphide mineralisation that previously produced a channel sampling intersection of two metres at 27.9 percent zinc, 958 grams per tonne silver.
Key sulphide zones from UBD0003 and UBD0002D1 are now to be sampled and submitted for full interval analyses at ALS in Perth as soon as possible.
At the same time, it’s worth noting that this is an early stage play and investors should seek professional financial advice if considering this company for their portfolio.
PSM managing director Jon Dugdale said, “We have made great progress at our Ubeong Project over the last 12 months and the drilling is now intersecting the massive and disseminated sulphide mineralisation we have been targeting.
“Following assessment of the initial results the drilling will continue in Q1 2018, testing the interpreted core of this large-scale porphyry-skarn base and precious metals system.”
UBD0003 is now at >270 metres and continues to drill skarn/limestone with minor disseminated sulphides.
Selected sulphide bearing intervals in UBD0003 (and UBD0002) will be half-cored and submitted for multi-element analyses at ALS in Perth over the coming weeks.
The next hole, UBD0004, will commence after winter during the first quarter of 2018, and will test northwards under the most intense zinc and copper geochemistry at the eastern end of the Taipan Target.
PSM will target the magnetic ‘core’ of the porphyry-skarn system and under the six metre thick copper bearing massive sulphide outcrop at the Viper Prospect (shown below).
PSM secures $1.9 million cash injection via oversubscribed placement
Equally positive news for the company is its announcement today that it has been settlement its recently completed share placement, with A$1.9 million received from the issue of 118.75 million ordinary shares to institutional and sophisticated investors.
Additionally, major shareholder Aurora Minerals Ltd (ASX:ARM) has committed to invest a further A$100,000 (subject to shareholder approval).
The company has also issued one free attaching option for every two shares subscribed in the placement, with an exercise price of 2.0 cents and an expiry date 18 months from the date of issue, resulting in the issue of 59,375,000 options to subscribers. PSM has also issued 21.6 million options to brokers who supported the placement.
“We are delighted by the overwhelming support of existing and new shareholders for this placement,” Dugdale said.
Funds raised will be used to continue the zinc-silver and copper-gold drilling program at Ubeong, to accelerate PSM’s graphite and lithium drill-targeting, and to complete graphite supply and offtake agreements.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.